本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Reviva Pharmaceuticals Holdings, Inc.

0.8690
+0.098112.73%
成交量:73.15萬
成交額:63.13萬
市值:1,105.98萬
市盈率:-0.16
高:0.9200
開:0.7961
低:0.7807
收:0.7709
52周最高:23.20
52周最低:0.5900
股本:1,272.70萬
流通股本:1,255.13萬
量比:1.23
換手率:5.83%
股息:- -
股息率:- -
每股收益(TTM):-5.4800
每股收益(LYR):-18.0520
淨資產收益率:-419.97%
總資產收益率:-80.35%
市淨率:1.28
市盈率(LYR):-0.05

資料載入中...

2021/03/22

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/22

重要事件披露

8-K - Current report
2021/03/22

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/04

重要事件披露

8-K - Current report
2021/01/20

重要事件披露

8-K/A [Amend] - Current report
2021/01/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/19

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/01/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/07

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/01/07

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/29

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/12/21

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/12/18

重要事件披露

8-K - Current report
2020/12/14

重要事件披露

8-K - Current report
2020/12/14

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/12/09

重要事件披露

8-K - Current report
2020/11/19

企業合併公告

425 - Prospectuses and communications, business combinations
2020/11/19

重要事件披露

8-K - Current report